Cargando…
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
AIMS/HYPOTHESIS: Oxidative stress plays a key role in the development of type 2 diabetes mellitus. We previously showed that the circulating antioxidant peroxiredoxin 4 (Prx4) is associated with cardiometabolic risk factors. We aimed to evaluate the association of Prx4 with type 2 diabetes risk in t...
Autores principales: | Abbasi, Ali, Corpeleijn, Eva, Gansevoort, Ron T., Gans, Rijk O. B., Struck, Joachim, Schulte, Janin, Hillege, Hans L., van der Harst, Pim, Stolk, Ronald P., Navis, Gerjan, Bakker, Stephan J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119240/ https://www.ncbi.nlm.nih.gov/pubmed/24893865 http://dx.doi.org/10.1007/s00125-014-3278-9 |
Ejemplares similares
-
Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All-Cause Mortality
por: Abbasi, Ali, et al.
Publicado: (2012) -
Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020) -
Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
por: Byambasukh, Oyuntugs, et al.
Publicado: (2019) -
Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study
por: Riphagen, Ineke J., et al.
Publicado: (2017) -
Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
por: Zelle, Dorien M., et al.
Publicado: (2013)